Register for our free email digests:
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The US Center for Medicare and Medicaid Services proposed downsizing its CJR joint replacement value-based payment model and outright canceling its cardiac procedure bundled payment model. Will the move discourage companies like Zimmer Biomet, Johnson & Johnson, and Medtronic, which have already invested in programs based on the value-based models?
Latest From Market Access
Six months after imposing stiff price controls on cardiac stents, India’s government slashed costs of knee implants by nearly 70%, saying the action was necessary to end “unethical profiteering.”
Conway, a champion of the US agency's move into value-based care, will take the helm at Blue Cross/Blue Shield of North Carolina.
Dr Charlie Davie, managing director of UCLPartners, a London-based Academic Health Science Partnership and one of the 15 UK Academic Health Science Networks, updates Medtech Insight on key changes in NHS market access policy this summer.
Medicare Proposal To Cover Outpatient Knee, Hip Procedures Raises Patient Selection, Bundling Questions
Improvements in technology surrounding knee and hip replacements means a shorter recovery time for patients, but a recent US CMS proposal to take the procedures off the "inpatient procedure only" list means surgeons will have to carefully choose Medicare patients that are appropriate for the outpatient setting, and payment bundles could be affected.
After eight years together, Insulet will be splitting from its exclusive European distributor Ypsomed and take full responsibility for the distribution, sales, marketing, training and support activities of its Omnipod insulin management system in that region. Insulet's president and chief operating officer, Shacey Petrovic told Medtech Insight how the Massachusetts-based company will embark on this next solo chapter.
In a bid to increase local products of medical equipment and reduce costs of importing expensive devices, Turkey has introduced financial incentives to attract multinationals to set up manufacturing facilities in the country. One priority area of this initiative will be medical imaging technologies.
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.